Thursday, August 8, 2013
Publication and contact
variants of a-synuclein (SNCA)
to classify neurodegenerative diseases
variants of SNCA could be useful as biomarkers for distinguishing between
subtypes of neurodegenerative diseases including Parkinson's disease (PD). In
cultured mouse neurons, expression of two different synthetic conformational
variants of human SNCA drove distinct patterns of SNCA and microtubule-associated
inclusion formation. In brain tissue samples from five patients with PD and
dementia, two showed expression of a single SNCA conformation, whereas the
other three showed expression of two SNCA conformations. Next steps include
studies to determine why different SNCA variants produce distinct disease
pathologies and to understand the significance of such differences.
Published online Aug. 8, 2013
Patent application filed
covering antibodies against the different SNCA variants; unavailable for
Guo, J.L. et al. Cell;
published online July 3, 2013;
Contact: Virginia M.Y. Lee, University of Pennsylvania
School of Medicine, Philadelphia, Pa.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]